Analyze Diet
Journal of veterinary internal medicine2015; 29(6); 1683-1688; doi: 10.1111/jvim.13627

Survival Time of Cross-Match Incompatible Red Blood Cells in Adult Horses.

Abstract: There is a markedly reduced half-life of transfused RBCs when donor and recipient cats or humans are cross-match incompatible. Only 10-20% of horses have naturally occurring alloantibodies. Therefore, cross-match testing before blood transfusion is not always performed. Objective: Cross-match incompatibility predicts shortened RBC survival time as compared to that of compatible or autologous blood. Methods: Twenty healthy adult horses. Methods: Prospective trial. Blood type, anti-RBC antibody screen (before and 1 month after transfusion) and major and minor cross-match determined 10 donor-recipient pairs. Two pairs were cross-match compatible, the remainder incompatible. Donor blood (4 L) was collected into citrate phosphate dextrose adenine-1, labeled with NHS-biotin, and transfused into recipients. Samples were collected at 1 hour and 1, 2, 3, 5, 7, 14, 21, 28, and 35 days after transfusion, and biotinylated RBCs were detected by flow cytometry. Horses were monitored for transfusion reaction during transfusion and daily for 5 days. Results: Cross-match incompatibility was significantly associated with decreased RBC survival time (P 1+) allogenic equine RBCs was 4.7 (95% CI, 3.2-6.2) days versus 33.5 (24-43) days for compatible pairings. Cross-match incompatibility was associated with acute febrile transfusion reaction (P = .0083). At day 30, only 1 horse had developed novel anti-RBC antibodies. Conclusions: Cross-match incompatibility was predictive of febrile transfusion reaction and shortened transfused RBC survival, but did not result in production of anti-RBC antibodies at 30 days. Cross-match testing before transfusion is recommended.
Publication Date: 2015-10-18 PubMed ID: 26478135PubMed Central: PMC4895677DOI: 10.1111/jvim.13627Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study discusses the decreased lifespan of transferred Red Blood Cells (RBCs) in horses when the donor and the receiving horse are cross-match incompatible. Findings suggest that cross-match incompatibility can lead to shorter RBC survival time, and even trigger acute febrile transfusion reaction, but does not result in the production of anti-RBC antibodies at 30 days. The study therefore proposes cross-match testing before blood transfusion to ensure compatibility and to avoid potentially harmful effects.

Methods

  • The study was a prospective trial conducted on twenty healthy adult horses. These horses were divided into 10 donor-recipient pairs based on blood type, anti-RBC antibody screen (before and 1 month after transfusion), and major and minor cross-match.
  • Two of these pairs were cross-match compatible, while the other eight were incompatible.
  • Blood was taken from the donor horse, and was labelled with NHS-biotin; it was then transfused into the receiving horse.
  • Post-transfusion, samples were collected at given intervals to study the presence of biotinylated RBCs using flow cytometry.
  • Throughout the process, horses were carefully monitored for any signs of transfusion reaction.

Results

  • The research found a significant association between cross-match incompatibility and decreased RBC survival time.
  • The average lifespan of transferred RBCs in the case of cross-match incompatibility was around 4.7 days, much lesser than the 33.5 days recorded for compatible pairings.
  • Instances of acute febrile transfusion reaction were noticed when there was cross-match incompatibility.
  • Interestingly, at the end of 30 days, only one horse had developed new anti-RBC antibodies.

Conclusions

  • Contrary to expectation, cross-match incompatibility didn’t lead to the development of anti-RBC antibodies at 30 days’ post-transfusion.
  • However, it did lead to shorter lifespan for the transferred RBCs, and was linked to instances of acute febrile transfusion reaction.
  • In light of these findings, the study recommends conducting a cross-match test prior to the transfusion to circumvent these potentially harmful effects.

Cite This Article

APA
Tomlinson JE, Taberner E, Boston RC, Owens SD, Nolen-Walston RD. (2015). Survival Time of Cross-Match Incompatible Red Blood Cells in Adult Horses. J Vet Intern Med, 29(6), 1683-1688. https://doi.org/10.1111/jvim.13627

Publication

ISSN: 1939-1676
NlmUniqueID: 8708660
Country: United States
Language: English
Volume: 29
Issue: 6
Pages: 1683-1688

Researcher Affiliations

Tomlinson, J E
  • Department of Clinical Studies - New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, PA.
  • Department of Clinical Sciences, Cornell University College of Veterinary Medicine, Ithaca, NY.
Taberner, E
  • Department of Clinical Studies - New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, PA.
Boston, R C
  • Department of Clinical Studies - New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, PA.
Owens, S D
  • Department of Pathology, Microbiology and Immunology, UC Davis School of Veterinary Medicine, Davis, CA.
Nolen-Walston, R D
  • Department of Clinical Studies - New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, PA.

MeSH Terms

  • Animals
  • Blood Group Antigens / classification
  • Blood Group Incompatibility / blood
  • Blood Group Incompatibility / veterinary
  • Blood Grouping and Crossmatching / veterinary
  • Blood Transfusion / veterinary
  • Erythrocyte Aging
  • Erythrocytes
  • Horses / blood

References

This article includes 22 references
  1. Bücheler J, Giger U. Alloantibodies against A and B blood types in cats.. Vet Immunol Immunopathol 1993 Oct;38(3-4):283-95.
    pubmed: 8291206doi: 10.1016/0165-2427(93)90088-lgoogle scholar: lookup
  2. Gurkan M, Arikan S, Ozaytekin E, Dodurka T. Titres of alloantibodies against A and B blood types in non-pedigree domestic cats in Turkey: assessing the transfusion reaction risk.. J Feline Med Surg 2005 Oct;7(5):301-5.
    pubmed: 15914059doi: 10.1016/j.jfms.2005.03.003google scholar: lookup
  3. Arikan S, Akkan HA. Titres of naturally occurring alloantibodies against feline blood group antigens in Turkish Van cats.. J Small Anim Pract 2004 Jun;45(6):289-92.
  4. GILMAN MA, SCHWARZ A, WALLERSTEIN H. Immunohematologic studies of the thoroughbred horse.. Am J Vet Res 1960 May;21:393-6.
    pubmed: 13850153
  5. Bailey E. Prevalence of anti-red blood cel antibodies in the serum and colostrum of mares and its relationship to neonatal isoerythrolysis.. Am J Vet Res 1982 Nov;43(11):1917-21.
    pubmed: 7181190
  6. Suzuki Y, Stormont C, Trommershausen‐Smith A. Alloantibodies: The blood groups they define. Proceedings of 1st International Symposium of Equine Hematology 1975;1:34–41.
  7. Zaruby JF, Hearn P, Colling D. Neonatal isoerythrolysis in a foal, involving anti-Pa alloantibody.. Equine Vet J 1992 Jan;24(1):71-3.
  8. Whiting J, David J. Neonatal isoerythrolysis. Compend Contin Educ Vet 2000;22:968–975.
  9. de Graaf-Roelfsema E, van der Kolk JH, Boerma S, van Haeringen H. Non-specific haemolytic alloantibody causing equine neonatal isoerythrolysis.. Vet Rec 2007 Aug 11;161(6):202-4.
    pubmed: 17693632doi: 10.1136/vr.161.6.202google scholar: lookup
  10. Owens SD, Snipes J, Magdesian KG, Christopher MM. Evaluation of a rapid agglutination method for detection of equine red cell surface antigens (Ca and Aa) as part of pretransfusion testing.. Vet Clin Pathol 2008 Mar;37(1):49-56.
  11. Harris M, Nolen-Walston R, Ashton W, May M, Jackson K, Boston R. Effect of sample storage on blood crossmatching in horses.. J Vet Intern Med 2012 May-Jun;26(3):662-7.
  12. Kallfelz FA, Whitlock RH, Schultz RD. Survival of 59Fe-labeled erythrocytes in cross-transfused equine blood.. Am J Vet Res 1978 Apr;39(4):617-20.
    pubmed: 646196
  13. Owens SD, Johns JL, Walker NJ, Librach FA, Carrade DD, Tablin F, Borjesson DL. Use of an in vitro biotinylation technique for determination of posttransfusion survival of fresh and stored autologous red blood cells in Thoroughbreds.. Am J Vet Res 2010 Aug;71(8):960-6.
    pubmed: 20673097doi: 10.2460/ajvr.71.8.960google scholar: lookup
  14. Mudge MC, Walker NJ, Borjesson DL, Librach F, Johns JL, Owens SD. Post-transfusion survival of biotin-labeled allogeneic RBCs in adult horses.. Vet Clin Pathol 2012 Mar;41(1):56-62.
  15. Socha WW, Rowe AW, Lenny LL, Lasano SG, Moor-Jankowski J. Transfusion of incompatible blood in rhesus monkeys and baboons.. Lab Anim Sci 1982 Feb;32(1):48-56.
    pubmed: 7078073
  16. Radin MJ, Eubank MC, Weiser MG. Electronic measurement of erythrocyte volume and volume heterogeneity in horses during erythrocyte regeneration associated with experimental anemias.. Vet Pathol 1986 Nov;23(6):656-60.
    pubmed: 3811130doi: 10.1177/030098588602300602google scholar: lookup
  17. Hata R, Sonoda M. Clinical and hematological observations on repeated experimental blood transfusions in horses. Exp Rep Equine Hlth Lab 1974;11:133–151.
  18. Wong PL, Nickel LS, Bowling AT, Steffey EP. Clinical survey of antibodies against red blood cells in horses after homologous blood transfusion.. Am J Vet Res 1986 Dec;47(12):2566-71.
    pubmed: 3800114
  19. Durham AE. Blood and plasma transfusion in the horse. Equine Vet Educ 1996;8:8–12.
  20. Tocci LJ, Ewing PJ. Increasing patient safety in veterinary transfusion medicine: an overview of pretransfusion testing.. J Vet Emerg Crit Care (San Antonio) 2009 Feb;19(1):66-73.
  21. Hurcombe SD, Mudge MC, Hinchcliff KW. Clinical and clinicopathologic variables in adult horses receiving blood transfusions: 31 cases (1999-2005).. J Am Vet Med Assoc 2007 Jul 15;231(2):267-74.
    pubmed: 17630896doi: 10.2460/javma.231.2.267google scholar: lookup
  22. Bailey E, Albright DG, Henney PJ. Equine neonatal isoerythrolysis: evidence for prevention by maternal antibodies to the Ca blood group antigen.. Am J Vet Res 1988 Aug;49(8):1218-22.
    pubmed: 3178019

Citations

This article has been cited 12 times.
  1. Kakoi H, Kikuchi M, Ishige T, Hirosawa Y, Tanaka S, Nagata SI. Monitoring the positive conversion of anti-erythrocyte antibodies in blood transfusion donor horses. J Equine Sci 2023 Jun;34(2):47-49.
    doi: 10.1294/jes.34.47pubmed: 37405070google scholar: lookup
  2. Kretsch CM, Alonso FH, Buktenica M, Heller MC. Agglutination and hemolytic crossmatching to determine transfusion reaction differences between large and small breed goats. J Vet Intern Med 2023 Jul-Aug;37(4):1594-1602.
    doi: 10.1111/jvim.16738pubmed: 37226646google scholar: lookup
  3. Jamieson CA, Baillie SL, Johnson JP. Blood Transfusion in Equids-A Practical Approach and Review. Animals (Basel) 2022 Aug 23;12(17).
    doi: 10.3390/ani12172162pubmed: 36077883google scholar: lookup
  4. Kamm JL, Riley CB, Parlane NA, Gee EK, McIlwraith CW. Immune response to allogeneic equine mesenchymal stromal cells. Stem Cell Res Ther 2021 Nov 12;12(1):570.
    doi: 10.1186/s13287-021-02624-ypubmed: 34772445google scholar: lookup
  5. Kakoi H, Kikuchi M, Ishige T, Nagata SI, Hirosawa Y, Tanaka S, Kishinami T. Investigation of erythrocyte antigen frequencies in draft horse populations in Japan to assess blood donor suitability. J Equine Sci 2021 Mar;32(1):17-19.
    doi: 10.1294/jes.32.17pubmed: 33776536google scholar: lookup
  6. Smith JS, Viall AK, Breuer RM, Walton RA, Plummer PJ, Griffith RW, Kreuder AJ. Preliminary Investigation of Bovine Whole Blood Xenotransfusion as a Therapeutic Modality for the Treatment of Anemia in Goats. Front Vet Sci 2021;8:637988.
    doi: 10.3389/fvets.2021.637988pubmed: 33748213google scholar: lookup
  7. Proverbio D, Perego R, Baggiani L, Ferrucci F, Zucca E, Nobile F, Spada E. Prevalence of Ca Blood Type and Alloantibodies in a Population of Horses from Italy. Animals (Basel) 2020 Jul 13;10(7).
    doi: 10.3390/ani10071179pubmed: 32668596google scholar: lookup
  8. Fenn MS, Bortsie-Aryee AD, Perkins GA, Mann S, Tomlinson JE, Wood EM, Mix SE, Stokol T. Agreement of stall-side and laboratory major crossmatch tests with the reference standard method in horses. J Vet Intern Med 2020 Mar;34(2):941-948.
    doi: 10.1111/jvim.15710pubmed: 32017276google scholar: lookup
  9. Kamm JL, Parlane NA, Riley CB, Gee EK, Dittmer KE, McIlwraith CW. Blood type and breed-associated differences in cell marker expression on equine bone marrow-derived mesenchymal stem cells including major histocompatibility complex class II antigen expression. PLoS One 2019;14(11):e0225161.
    doi: 10.1371/journal.pone.0225161pubmed: 31747418google scholar: lookup
  10. Casenave P, Leclere M, Beauchamp G, Blais MC. Modified stall-side crossmatch for transfusions in horses. J Vet Intern Med 2019 Jul;33(4):1775-1783.
    doi: 10.1111/jvim.15519pubmed: 31102487google scholar: lookup
  11. Luethy D, Owens SD, Stefanovski D, Nolen-Walston R, Giger U. Comparison of Tube, Gel, and Immunochromatographic Strip Methods for Evaluation of Blood Transfusion Compatibility in Horses. J Vet Intern Med 2016 Nov;30(6):1864-1871.
    doi: 10.1111/jvim.14604pubmed: 27770509google scholar: lookup
  12. Miglio A, Rocconi F, Cremonini V, D'Alessandro A, Reisz JA, Maslanka M, Lacroix IS, Tiscar G, Di Tommaso M, Antognoni MT. Effect of leukoreduction on the metabolism of equine packed red blood cells during refrigerated storage. J Vet Intern Med 2024 Mar-Apr;38(2):1185-1195.
    doi: 10.1111/jvim.17015pubmed: 38406982google scholar: lookup